A dverse events (AEs) and adverse drug events (ADEs) remain an important concern in the high acuity setting of the pediatric intensive care unit. In this multicenter study by Dr. Agarwal and coworkers, contemporary methodology for detecting these events is used to characterize AEs and ADEs in 15 pediatric intensive care units (PICUs). Patient safety remains an issue of national importance for hospitals, regulators, insurance companies, payors, and patients (1-7). Traditional efforts to detect AEs, including voluntary reports (incident reports), administrative databases, and unstructured chart review, each have a role in detecting harmful events. However, in isolation, none of these identify the number of AEs that are detected by the trigger tool methodology (6 -10) . As more hospitals integrate the tenets of high reliability organization theory, the ability to accurately measure AEs is a critical need (11) . The trigger tool methodology has emerged as a practical, reliable, and effective strategy for iatrogenic AE/ADE detection (3, 5, 6, 12, 13) . Triggers, defined as "occurrences, prompts, or flags found on review of the medical record that 'trigger' a further investigation to determine the presence or absence of an AE/ADE" (5, 12) , promote a more focused and efficient chart review and thus identify more AEs/ADEs than previously used methods.
The PICU is a high-acuity environment in which there is potential for a high risk of AEs/ADEs (14) . The patient population is diverse in both diagnosis and age. A better understanding of the types and severity of AEs/ADEs that occur in this population should allow more targeted safety interventions to prevent such events in the future (15, 16) . To date, one single-institution study, using a modified trigger tool in the PICU, identified a rate of 1.95 AEs per patient and 53 AEs per 100 patient-days (14) . Because there is evidence that the risk of AEs/ADEs is population-specific (3, (5) (6) (7) 12) and the only prior PICU trigger tool trial was limited to one site (14) , we initiated a multisite study to identify more comprehensively the epidemiology of AEs/ADEs in the PICU population.
The aims of this study were to: 1) determine the epidemiology of AEs/ADEs, including the rate, type, severity, and preventability of AEs occurring in PICUs in the United States; 2) identify specific population characteristics associated with increased risk of AEs/ ADEs in the PICU; and 3) develop and test a PICU specific trigger tool to facilitate identification of PICU AEs and ADEs.
PATIENTS AND METHODS

Design, Setting, and Patients
This was a cross-sectional, retrospective review of randomly selected PICU patient charts from 15 hospitals across the United States. Inclusion criteria required that patients were in the PICU for a minimum of 2 days and were discharged, transferred out, or died in the PICU between September 1, 2005 and December 31, 2005. Postoperative cardiac surgery patients were excluded, because they are often cared for in units outside of the PICU and they likely need their own population-specific set of triggers. Institutional Review Board approval was obtained at each participating site.
Intervention
Development of PICU Trigger Tool. A panel of eight PICU physicians (J.E.S., G.L., B.J.C., V.C., N.M.T., S.A.S., L.W.H., S.A.) and two patient safety experts (P.S., D.C.) developed a comprehensive list of AEs, including ADEs, relevant to PICU patients. This initial list was generated by extrapolating AEs from the neonatal intensive care unit (ICU) trigger tool (6), the Pediatric ADE trigger tool (7), the adult ICU trigger tool (3), the Institute for Healthcare Improvement ADE trigger tool (5), a pilot PICU trigger list (14) , and from personal experience. An initial list of 48 potential AEs was narrowed down to 32 high-risk or high-volume AEs, using a modified Delphi method (17) . From this list, a draft trigger tool consisting of 42 triggers thought likely to identify these 32 AEs was created. After pilot testing at eight sites, using 89 charts, this list was reduced to 22 triggers after removal of triggers with a low positive predictive value, perceived ambiguity, or those resulting in inefficiencies during the chart review process (Table 1) .
Recruitment and Training. Participating PICUs were recruited from the Pediatric Pharmacy Advocacy Group, Glaser Pediatric Research Network, and Child Health Corporation of America. A training process identical to that of the neonatal ICU trigger tool study was initiated with all sites being encouraged to review four training charts followed by a series of webcasts/conference calls to ensure full understanding of the trigger tool methodology used in the study (6) . Evidence exists that there is a high degree of interrater reliability between reviewers who received similar training in the use of trigger tools (6, 12) .
Subject Selection and Definitions. The final PICU trigger tool, an instruction manual containing detailed definitions of triggers, likely associated predefined AEs/ADEs and case examples (Appendix A shows case examples; http://www.chca.com presents the full PICU trigger instruction manual), and data collection sheets were distributed in January 2006. Eligible subjects at each site were included in a master list from which 50 subjects were randomly selected (18) . We defined an AE (inclusive of ADEs) as "an Objectives: Selection of relevant patient safety interventions for the pediatric intensive care (PICU) requires identification of the types and severity of adverse events (AEs) and adverse drug events (ADEs) that occur in this setting. The study's objectives were to: 1) determine the rates of AEs/ADEs, including types, severity, and preventability, in PICU patients; 2) identify population characteristics associated with increased risk of AEs/ADEs; (3, 5) . Inherent in this definition are the beliefs that an AE may occur despite the correct care being given under correct circumstances and that harm should be examined from the patient's perspective (12) . For example, if an endotracheal tube (ETT) is found to be at the thoracic inlet (high) and the patient requires paralysis and a repeat chest radiograph to reposition the ETT, then this patient has suffered a temporary AE (malpositioned ETT), resulting in a series of interventions to address it (repeat chest radiograph, paralysis). A second example reflects that a peripheral intravenous catheter placed appropriately, but which then infiltrates after a medication infusion, may result in varying degrees of harm from the patient's perspective. If a peripheral intravenous catheter was noted to be resistant to flushing and then a medication, such as sodium bicarbonate (known to cause skin necrosis if injected in tissues), is infused inadvertently subcutaneously resulting in tissue necrosis, then a preventable AE would have occurred. Similarly, an ADE was defined as "an injury, large or small, caused by the use (including nonuse) of a drug identified during the PICU stay" (3, 5) . The definition of "preventability" was determined by individual sites based on local interpretations of each event but in general was based on the premise that the AE may have been avoidable, given the appropriate implementation of evidence-based medicine and/or appropriate use of available resources.
Data Collection. Chart review methodology was identical to prior pediatric trigger tool studies and is described elsewhere (6, 7, 12) . The primary chart reviews were conducted locally by nurses or PICU physicians. Charts were reviewed for the presence or absence of the 22 triggers and/or AEs (including ADEs). Each identified trigger prompted an in-depth investigation for presence or absence of associated AEs/ADEs. After initial review by the primary chart reviewers, a summary of findings were presented to the PICU physician and a pharmacist to confirm/deny determinations of AE classifications, occurrence, preventability, earlier identification, more effective mitigation, and severity category (Table 2) (19). In case of discrepancy, the PICU physician's determinations were considered final. Patient demographic data and severity of illness (using the Pediatric Multiple Organ Dysfunction Score [P-MODS]) (20) were also recorded. Completed de-identified data collection sheets were sent to Child Health Corporation of America for database entry. Data were reviewed for completeness, and all questions or discrepancies were referred to the appropriate site for resolution. Accuracy of data entry into the database was reviewed for 100% of sheets submitted.
Outcomes
Primary outcomes included: 1) AE/ADE rates per 100 patient-days and per patient; and 2) type and severity level of AEs/ADEs. Secondary outcomes included: 1) preventable AE/ ADE rates per 100 patient-days and per patient; 2) cumulative risk of AEs/ADEs per additional PICU day; and 3) the percentage of AEs that were associated with a hospital incident report. Hospital demographics and trigger tool characteristics, such as positive predictive value of PICU trigger list (defined as the number of times a trigger independently identified an AE divided by the total number of times triggers were identified) and mean time for chart review, were collected.
Statistical Analysis
Predictors of AEs/ADEs per 100 patientdays were identified, using univariate and multivariate Poisson regression; variability in length of stay was accounted for by using an offset term equal to the logarithm of the follow-up times (21) . Variables included in the multivariate analyses were gender, age (0 -29 days, 30 -364 days, 1-5 yrs, 6 -12 yrs, Ն13 yrs), length of stay (2 days, 3 or 4 days, 5-8 days, 9 -15 days, Ͼ15 days), intubation at any time during PICU stay, mortality, admission service type (medical or surgical), and P-MODS. To allow for possible overdispersion that might violate the restrictive assumptions of the Poisson distribution, negative binomial regression was used when necessary. Preventable AE/ADE rates were examined similarly. Expected increase in number of AEs/ADEs was estimated with Poisson regression for count data. Sensitivity analyses were done to examine robustness of the results to patients with Ͼ5 AEs. All statistical analysis was performed using SAS version 9.1 (SAS Institute, Cary, NC).
RESULTS
Aggregate Data
A total of 1488 AEs, including 256 ADEs (17.2% of total AEs), were identified in 734 patient medical records from 15 PICUs across the United States. At least one AE was found in 454 (62%) subjects. Study population demographics are listed in Table 3 . A total of 2816 triggers were detected, resulting in identification of 1250 (84%) of the total AEs found. The positive predictive value of the aggregate PICU trigger list was 0.44 (range, 0.2-1.25). The mean time for chart reviews was 24.7 mins per reviewer. Only 4% of AEs had an associated incident report filed, a low percentage consistent with previous trigger tool studies (6, 9) .
AE Characteristics (Inclusive of ADEs)
The most common AEs were catheter complication, uncontrolled pain, and Table 2 . Severity categories of adverse events based on the system used for classifying medication errors by the National Coordinating Council for Medication Error Reporting and Prevention (Categories E through I) (18) Category E:
Contributed to or resulted in temporary harm to the patient and required intervention Category F:
Contributed to or resulted in temporary harm to the patient and required initial or prolonged hospitalization Category G:
Contributed to or resulted in permanent patient harm Category H:
Required intervention to sustain life Category I:
Contributed to or resulted in the patient's death ETT malposition for which the percentage deemed preventable ranged from 48.6% to 82.2% (Table 4) . Of all AEs, 27% were classified as worse than category E ("contributed to or resulted in temporary harm to the patient and required intervention"), with 151 (10%) events classified as category G ("contributed to or resulted in permanent patient harm") or greater ( Figs. 1 and 2 ). In the subset of ADEs, none were classified as category I ("contributed to or resulted in the patient's death"). Of all AEs, 45% were deemed preventable, 20% could have been identified earlier, and 22% could have been mitigated more effectively. Eighty-seven percent of the inciting events for the AE occurred in the PICU, 9% occurred in the hospital but outside of the PICU, and 3% occurred outside the hospital.
Detailed Data
Adverse Events Table 5 shows detailed data on the total crude AE rates and frequencies in subpopulations. Overall, the mean AE rate was 28.6 events per 100 patientdays. Surgical patients, intubated patients, deceased patients, and patients with P-MODS between 9 and 12 experienced higher rates of AEs per 100 patient-days.
In a multivariate negative binomial regression model, significant predictors for AEs were surgical patients (p ϭ .02), deceased patients (p Ͻ .0001), and patients intubated at any time during the PICU stay (p ϭ .002) (Table 6 ). Specifically, the expected number of AEs per 100 patientdays is 1.2 times higher for a surgical than for a medical patient, 0.5 times lower for a living than for a deceased patient, and 1.8 times higher for an intubated than for a never intubated patient. Adjusted for other variables, a 1-day increase in length of stay yields a 5.3% increase in the expected number of AEs (unadjusted, a 7.6% increase). Figure 3 displays the cumulative risk of AEs for different high-risk patient types. Table 7 shows data on the crude ADE rates and frequencies in subpopulations. Overall, the mean ADE rate was 0.3 per patient and 4.9 per 100 patient-days. Patients aged Ն13 yrs were associated with higher rates of ADEs per 100 patientdays.
ADEs
Multivariate Poisson regression modeling found that the only significant predictor was age (p Ͻ .0001). Adjusted, the expected number of ADEs per 100 patient-days increased multiplicatively by 1.04 for every 1-yr increase in age (i.e., a 1-yr increase corresponds to 4% expected increase; a 10-yr increase corresponds to 48% expected increase).
Adjusted, a 1-day increase in length of stay yields a 1.6% increase in the expected number of ADEs (unadjusted, a 1.8% increase). Figure 4 displays the cumulative risk of ADEs for different highrisk patient types.
Preventability
Overall, the mean preventable AE rate was 13.0 events per 100 patient-days. Surgical, deceased, age 30 days-5 yrs, and P-MODS between 9 and 12 subtypes experienced significantly higher rates of preventable AEs per 100 patient-days. Significant predictors of preventable AE rate were age, patient type, and hospital disposition after adjusting for other variables. The mean preventable ADE rate was 2.1 events per 100 patient-days. Surgical patients experienced significantly higher rates of preventable ADEs per 100 patient-days after adjusting for other variables (Tables 5-7) .
Mortality
The mean mortality rate was 0.65 per 100 patient-days. Significantly higher mortality rates were found in patients intubated at any point during their PICU stay or with a high P-MODS. Adjusted for other variables, intubation status remained a significant predictor of mortality (p ϭ .02) ( Table 6 ).
Excluding Patients With More Than Five Events
There were 66 patients with Ͼ5 AEs, two patients with Ͼ5 ADEs, 24 patients with Ͼ5 preventable AEs, and no patients with Ͼ5 preventable ADEs. Conclusions for AE/ADE rates and preventable ADE rates remained the same when analyses were repeated, excluding patients with Ͼ5 AEs/ADEs/preventable ADEs. After excluding patients with Ͼ5 preventable AEs, analyses revealed age was no longer significant after adjustment for other variables.
DISCUSSION
This study is the largest detailed review of PICU-associated AEs yet published. It represents the review of 734 PICU patient admissions, excluding postoperative cardiac surgery patients, and 5201 PICU-days from 15 PICUs across the United States. The results of this study form the basis for a better understanding of the frequency of AEs, the most common types of AEs, and the characteristics of patients at greatest risk for AEs within the PICU setting.
Our findings of an AE rate of 2.03 per patient in the PICU setting (28.6 per 100 patient-days) and an ADE rate of 0.3 per patient (4.9 per 100 patientdays) are substantially higher than reported rates found in any previous multicenter study of pediatric patients. The two prior national trigger tool studies (6, 7) in pediatrics identified AE rates in the high-risk neonatal ICU of 0.74 per patient and ADE rates in children's hospitals of 0.11 per patient (1.57 per 100 patient-days). Prior studies (22, 23) , using other methodologies, reflected even lower rates. Interestingly, the AE rate of 2.03 per patient is virtually identical to that identified in the adult ICU (2.02 per patient) study (3) and in the singleinstitution PICU (1.95 per patient) study (14) , using trigger methodology. However, the AE rates per 100 patientdays in our study and the singleinstitution PICU study were substantially higher than in the adult ICU (28.6 and 52.7 vs. 11.3 per 100 patient ICUdays, respectively), supporting our assertion that the diverse age range (age, 1 day-18 yrs) and diagnoses of patients (medical and surgical) cared for in PICUs indicate a high-risk environment for AEs.
One notable finding in this study is the association of increasing risk of ADEs with age. For each additional 1-yr increase in age, our model showed a 4% increase in ADE rates. Also, patients aged Ն13 yrs had a significantly higher crude rate of ADEs than the combined younger age groups. One possible explanation is that the standard use of weight-based dosing of medications, including high-risk analgesic and inotropic drugs (frequently written in mg/ kg/hr or g/kg/min), may result in doses for adolescents exceeding adult standard dosing practices.
Surgical patients, who have higher AE rates than medical patients in adult populations (24) , emerged as being at significantly higher risk than medical patients within the PICU as well. Surgical patients had significantly higher AE rates, preventable AE rates, and preventable ADE rates than medical patients when adjusted for other risk factors. This finding is consistent with the increased rate of AEs and preventable AEs described in the single-institution PICU trigger study (14) . Postoperative patients are likely to have sedation/ pain-related issues in addition to multiple catheters, which would put them at risk for AEs in the most common PICU AE categories (catheter complication and uncontrolled pain) found in our study. Furthermore, if these surgical patients are intubated, they are at high risk for ETT malposition, possibly resulting from multiple transports to and from the operating room and off and on the transport gurneys. These results suggest that surgical patients are a high-risk population within the PICU that deserves special focus for AE reduction.
Also noteworthy is that PICU patients who died, even after adjusting for significant risk factors, such as intubation and surgical status, had significantly higher rates of AEs and preventable AEs than did those patients who survived. In addition, the association of higher total and preventable AE rates with mortality is intriguing and worthy of further study.
The most common AEs in this study were categorized as catheter complication (including infiltrated peripheral intravenous catheters), uncontrolled pain, and ETT malposition with the majority of these events classified as preventable. These AE categories are similar to those described in the single-institution PICU trigger study, which revealed the most common preventable AEs categories to be sedation/pain, skin (including infiltrated peripheral intravenous catheters), and medical device complications (including vascular catheter complications) (14) . Given the consistency of these findings in two separate studies, as well as the high proportion of AEs in these categories being classified as preventable, we suggest that these AE categories be the immediate focus of targeted, evidence-based safety interventions to reduce the overall risk of AEs in the PICU.
Our study found only one in six AEs to be medication-related. This low proportion of ADEs compared with total AEs is consistent with other pediatric and adult studies (3, 23) . Also consistent with prior studies of pediatric ADEs, the vast majority were of low severity (Category E) (19), and none were thought to contribute to death. Given the consistency of these findings across multiple studies and patient populations, efforts to reduce medication error and ADEs alone (25-34) will be necessary but not sufficient to impact substantially the overall risk of AEs in critically ill children. This interpretation is consistent with consensus statements, suggesting that patient safety efforts often targeting medications have had little impact on national AE statistics (35, 36) . Although hospitals should continue aggressive efforts to reduce medicationrelated harm, or ADEs, our findings support efforts to accelerate prevention strategies to areas of nonmedicationrelated harm as well (37) (38) (39) (40) .
This study had several limitations. First, there is no gold standard to identify AEs with which we can compare our findings. Therefore, we are still likely underestimating the true rate of AEs in the PICU. This limitation is apparent in that 16% of all AEs in this study were identified without the use of the trigger tool. Second, despite our attempts to standardize the use of the trigger tool and the interpretation of findings with a rigorous training curriculum, the use of the trigger tool in particular, the determination of an event to be an ADE or preventable, is subjective and susceptible to certain biases that could affect the outcomes in uncertain ways (41) . A third limitation is that we conducted this study in largely academic PICUs, so our results may have limited generalizability to non- academic PICUs. Finally, we used the recently described P-MODS tool for severity adjustment, as the majority of our sites did not use the Pediatric Risk of Mortality methodology (42) (43) (44) . Although the P-MODS successfully predicted our study population to have Ͻ10% mortality, it has yet to be validated in larger PICU populations (20) .
CONCLUSIONS
This study is the most comprehensive assessment of the prevalence of AEs/ADEs in the high-risk PICU setting yet published. In addition, this study provides a novel PICU specific trigger tool to help hospitals assess and measure their AE rates. These results should provide the foundation for targeted, evidence-based prevention strategies to decrease the substantial risk of AEs in this vulnerable pediatric patient population. Trigger tool methodology is an emerging strategy for the detection of AEs and ADEs which can be successfully applied in PICUs. Not surprisingly, issues such as multiple organ failure and age-related factors may contribute importantly to the prevalence of these adverse events in the PICU and signal special attention to these and other factors associated with high risk events.
